Marijuana’s psychoactive compound may alter brain wiring in adolescents

In a mouse study designed to explore the impact of marijuana’s major psychoactive compound, THC, on teenage brains, Johns Hopkins Medicine researchers say they found changes to the structure of microglia, which are specialized brain immune cells, that may worsen a genetic predisposition to schizophrenia.

Ibex, PathPresenter Partner on AI-Powered Digital Pathology

What You Should Know: – Ibex Medical Analytics (Ibex), a pioneer in AI-powered cancer diagnostics, and PathPresenter, the leading global platform for pathology image sharing,

March 7, 2024

Corrected: Entrada raises $100M for Duchenne development; eFFECTOR winds down

Plus, news about NeuroBo, Vico Therapeutics, Takeda, Checkpoint Therapeutics, CombiGene, Spark Therapeutics, ANI, Alimera Sciences and OSE Immunotherapeutics: Entrada Therapeutics raises $100M from stock sale

June 25, 2024

CSL’s ‘big’ post-heart attack drug fails in Phase III trial

Share this article CSL’s AEGIS-II study for its MI drug CSL112 enrolled 18,200 participants across 850 sites worldwide. Image Credit: viewimage / Shutterstock. Australian CSL

February 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.